As of 31 Dec 2025, 22 institutional investors reported holding 1,006,338 shares of Tiziana Life Sciences Ltd - COMMON SHARES (TLSA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,006,338 | $1,499,188 | +$328,007 | $1.49 | 22 |
| 2025 Q3 | 4,021,743 | $8,683,234 | +$546,890 | $2.16 | 30 |
| 2025 Q2 | 1,141,026 | $1,797,401 | -$72,992 | $1.58 | 29 |
| 2025 Q1 | 2,998,372 | $3,249,229 | +$2,269,460 | $1.08 | 32 |
| 2024 Q4 | 1,081,847 | $753,509 | -$957,265 | $0.70 | 34 |
| 2024 Q3 | 1,860,010 | $1,779,369 | +$894,810 | $0.96 | 29 |
| 2024 Q2 | 924,120 | $850,463 | +$107,206 | $0.92 | 25 |
| 2024 Q1 | 745,805 | $329,948 | +$2,110 | $0.45 | 17 |
| 2023 Q4 | 788,263 | $439,827 | -$2,661 | $0.56 | 19 |
| 2023 Q3 | 782,198 | $517,885 | -$62,103 | $0.66 | 21 |
| 2023 Q2 | 869,851 | $596,842 | -$261,032 | $0.68 | 18 |
| 2023 Q1 | 1,075,723 | $1,150,306 | -$2,530,488 | $1.09 | 18 |
| 2022 Q4 | 5,278,985 | $3,165,294 | -$33,459 | $0.60 | 20 |
| 2022 Q3 | 5,319,993 | $4,143,000 | -$3,698 | $0.77 | 20 |
| 2022 Q2 | 5,326,700 | $3,968,000 | -$313,897 | $0.74 | 19 |
| 2022 Q1 | 5,745,904 | $6,038,000 | -$48,644 | $1.05 | 21 |
| 2021 Q4 | 5,814,911 | $5,633,000 | +$5,633,001 | $0.96 | 19 |